SANTA CLARA, Calif. – Agilent Technologies Inc. (NYSE: A) today announced that scientists using the company’s comparative genomic hybridization (CGH) technology have shown that cancer cell lines, which are broadly used in all aspects of biomedical research, may have vast differences in their genetic makeup, even when grown in the same batch. As a result, […]
SAN DIEGO–(BUSINESS WIRE)– Illumina, Inc. (NASDAQ: ILMN) announced today that Philip W. Schiller has joined the company’s Board of Directors. Schiller is currently Apple’s Senior Vice President of Worldwide Marketing and is a member of Apple’s executive team responsible for the company’s product marketing, developer relations, business marketing, education marketing, international marketing and App Store […]
Sengenics Announces Commercial Partnership with RayBiotech for its Immunome Protein Array Technology
Sengenics, a genomics and proteomics-based research and diagnostics services company and Raybiotech, a leading USA-based global provider of ELISA and multiplex protein detection technologies, announced that they have entered into a commercial partnership to co-brand Sengenics’ flagship protein array platform, Immunome. Sengenics Commercial Director, Matthew Rawlings, said, “The Raybiotech-Sengenics relationship is a very exciting commercial […]
San Diego, CA –– BioMed Realty announced that Illumina, Inc. (NASDAQ: ILMN), a world leader in genomics focused on improving human health by unlocking the power of the genome, has signed a 10 year lease at BioMed Realty’s i3 campus, a 316,000 square foot development currently under construction in the University Towne Centre (UTC) life […]
WALTHAM, Mass. & SANTA CLARA, Calif. – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, and Affymetrix, Inc. (NASDAQ: AFFX), a leading provider of cellular and genetic analysis products, announced that Thermo Fisher has completed its previously announced acquisition of Affymetrix for $14.00 per share in cash, for a total purchase […]
WALTHAM, Mass. – Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, issued the following statement regarding Affymetrix, Inc.’s (NASDAQ: AFFX) press release dated March 28, 2016: JP Morgan is acting as financial advisor to Thermo Fisher, and Wachtell, Lipton, Rosen & Katz is serving as legal counsel.“We are pleased that the […]
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ: AFFX, “Affymetrix” or “the Company”) today announced that the Company’s Board of Directors (the “Board”), in consultation with its legal and financial advisors, has determined that the unsolicited merger proposal submitted by Origin Technologies Corporation, LLC (“Origin”) on March 22, 2016 does not constitute a Superior Proposal, as […]
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ: AFFX, “Affymetrix” or the “Company”) announced that the Company’s Board of Directors has informed Origin Technologies Corporation, LLC (“Origin”) that the Company will engage in discussions with Origin regarding its unsolicited merger proposal submitted on March 22, 2016 to acquire the Company for $17.00 per share in an […]
SANTA CLARA, Calif. – Affymetrix, Inc. (NASDAQ:AFFX, “Affymetrix” or the “Company”) announced that the Company’s Board of Directors, in consultation with its legal and financial advisors, has determined that the new unsolicited merger proposal submitted by Origin Technologies Corporation, LLC (“Origin”) on March 22, 2016, could reasonably be expected to lead to a Superior Proposal, […]
SANTA CLARA, Calif. – Affymetrix Inc. (NASDAQ: AFFX) Affymetrix announced that it has reviewed the proposal made by Origin Technologies Corporation, LLC (“Origin”) on March 18 for a transaction in which the stockholders of Affymetrix would receive $16.10 per share in cash. In reviewing the proposal, the Board of Directors notes that Origin appears to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
